Aspect Biosystems

Aspect Biosystems

Aspect Biosystems is a biotechnology company pioneering the development of a novel category of cellular medicines designed to replace or restore biological function and deliver curative therapies for some of the most elusive diseases. Aspect is developing these bioengineered cellular medicines by applying its full-stack tissue therapeutic platform, which integrates proprietary AI-powered bioprinting technology, therapeutic cells, hypoimmune cell engineering, and advanced biomaterials. Aspect is

Est. revenue
$10M–$20M
Total raised
$253M
Latest round
Grant
Employees
150

Funding & revenue at Aspect Biosystems

How well capitalized the business is — useful context before you scope a fractional engagement or negotiate a rate.

Estimated annual revenue

$10M–$20M

Modeled range, not company-reported

Total capital raised

$253M

26 known investors

Latest round

Grant · $56.8M

Apr 2026

Investors

Civilization VenturesDimension CapitalE-FundEndure CapitalGenome British ColumbiaGovernment of British ColumbiaGovernment of CanadaHedgewoodHeron Rock FundInnovate BCJDRF T1D FundNational Research Council of Canada Industrial Research Assistance ProgramNovo NordiskPacific Economic Development CanadaPage One VenturesPallasite VenturesPangaea VenturesRadical VenturesRelentless Pursuit PartnersRhino VenturesRising TideStem Cell Network (SCN)Tom WilliamsUBC Seed Fund

Growth signals

How fast Aspect Biosystems is adding people, roles, and audience.

Employees

150

Reported band 51-200

LinkedIn followers

29.2K

+19.8% year over year

Headcount change

MoM
+0.7%
+1 people
QoQ
+4.9%
+7 people
6mo
+5.6%
+8 people
YoY
+22%
+27 people
2yr
+32.7%
+37 people

Team composition

Where Aspect Biosystems concentrates its people — a read on which function a fractional leader would plug into.

By function

  • Research4429%
  • Operations149%
  • Engineering149%
  • Business Development149%
  • Quality Assurance107%
  • Accounting53%
  • Entrepreneurship43%
  • Community And Social Services43%

By region

  • Canada107
  • British Columbia, Canada98
  • Greater Vancouver Metropolitan Area96
  • Vancouver, BC78
  • United States27
  • California, United States22

Inside Aspect Biosystems

What the business focuses on, where it operates, and how employees rate it.

Specialties

bioprintingregenerative medicinetherapeutic developmentcell therapy

Categories

3D PrintingArtificial Intelligence (AI)BiotechnologyHealth CareLife ScienceBiotech & PharmaceuticalsPharmaceutical and biotechnology

Markets

PRIVATE

Competitors

Companies in the same market as Aspect Biosystems.

http://www.altoslabs.comhttp://www.zetamatrix.comhttp://www.clexbio.comhttp://www.poietis.comhttp://www.ecmtherapeutics.comhttp://www.regemat3d.comhttps://www.cyfusebio.com/en/index.htmlhttp://www.hcs-pharma.comhttp://asteriasbiotherapeutics.com/http://www.AltisBiosystems.comhttp://www.discgenics.comhttps://www.appiabio.com/http://bioarray.ushttps://ankasaregenerativetherapeutics.com/https://stempharm.com/http://sunpbiotech.com

Aspect Biosystems in the news

Recent coverage picked up alongside the firmographic refresh.

Funding, revenue, headcount, and hiring figures are third-party estimates from public sources and are not confirmed by the company. Last refreshed November 11, 2026.

About this page

This company page is automatically generated based on publicly available job postings. Company information is sourced from publicly available data and may not be complete. If you represent Aspect Biosystems, you can claim this page to manage and enhance it.